| scholarly article | Q13442814 |
| P50 | author | Jiafu Ji | Q56444638 |
| P2093 | author name string | Xin Chen | |
| Coral Ho | |||
| Ji Zhang | |||
| Siu Tsan Yuen | |||
| Suet Yi Leung | |||
| Annie S Y Chan | |||
| Dong Li Guo | |||
| Wai Yin Tsui | |||
| P2860 | cites work | Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases | Q24313265 |
| The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells | Q24314491 | ||
| Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Coexpression of ephrin-Bs and their receptors in colon carcinoma | Q28211031 | ||
| Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor | Q28211704 | ||
| APC mutations occur early during colorectal tumorigenesis | Q28274764 | ||
| Identification of Protein-Tyrosine Kinase Genes Preferentially Expressed in Embryo Stomach and Gastric Cancer | Q28298219 | ||
| Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB | Q28508041 | ||
| Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration | Q28587140 | ||
| The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells | Q31057640 | ||
| EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity | Q31148681 | ||
| Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction | Q31813080 | ||
| Eph receptors and ephrin ligands: embryogenesis to tumorigenesis | Q34103639 | ||
| Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. | Q34268571 | ||
| Ephrins are not only unattractive | Q34612363 | ||
| Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. | Q35122385 | ||
| Variation in gene expression patterns in human gastric cancers | Q35670324 | ||
| EphB receptor activity suppresses colorectal cancer progression | Q40405920 | ||
| Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening | Q40430101 | ||
| Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer | Q40527387 | ||
| EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer | Q40590849 | ||
| The Eph family: a multitude of receptors that mediate cell recognition signals | Q41605977 | ||
| Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis. | Q44587842 | ||
| Expression of Ephb2 and Ephb4 in breast carcinoma | Q44804369 | ||
| EphB2 is a prognostic factor in colorectal cancer | Q46413396 | ||
| Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer | Q48382544 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 454-464 | |
| P577 | publication date | 2005-11-04 | |
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours | |
| P478 | volume | 27 |
| Q41662329 | A review on Eph/ephrin, angiogenesis and lymphangiogenesis in gastric, colorectal and pancreatic cancers |
| Q42280200 | A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy |
| Q40095672 | Activation of EphA4 and EphB2 Reverse Signaling Restores the Age-Associated Reduction of Self-Renewal, Migration, and Actin Turnover in Human Tendon Stem/Progenitor Cells. |
| Q53485869 | Alterations in the thymocyte phenotype of EphB-deficient mice largely affect the double negative cell compartment. |
| Q50593562 | An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth. |
| Q33302514 | Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line |
| Q60305702 | Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells |
| Q53187965 | Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas. |
| Q38048249 | Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue |
| Q35783568 | Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling |
| Q37912495 | Control of cell adhesion and compartmentalization in the intestinal epithelium |
| Q55286883 | Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers. |
| Q37450404 | Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. |
| Q50232638 | Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer. |
| Q37824603 | EPH-EPHRIN in human gastrointestinal cancers |
| Q33245402 | EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis |
| Q38008492 | Eph and ephrins in epithelial stem cell niches and cancer. |
| Q34527304 | Eph receptor tyrosine kinases in cancer stem cells |
| Q35370195 | Eph receptors and ephrins as targets for cancer therapy |
| Q38209232 | Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics |
| Q37971530 | Eph/ephrin signaling in cell-cell and cell-substrate adhesion. |
| Q40074110 | EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. |
| Q38897586 | EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. |
| Q36179161 | EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion |
| Q38778764 | EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer |
| Q39926049 | EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis. |
| Q37160698 | Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival. |
| Q37620142 | Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses |
| Q39860968 | Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases |
| Q42544255 | Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease |
| Q54593908 | High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability. |
| Q33778296 | High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway |
| Q92617482 | Hypoxia-induced EPHB2 promotes invasive potential of glioblastoma |
| Q35222185 | Identification of alterations in DNA copy number in host stromal cells during tumor progression |
| Q46080136 | In situ validation of an intestinal stem cell signature in colorectal cancer |
| Q54338851 | Increased EphB2 expression predicts cholangiocarcinoma metastasis. |
| Q54626344 | Influence of A9 region mutation in EphB2 gene in the prognosis of patients with colorectal adenocarcinoma. |
| Q50454825 | Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis |
| Q39722494 | Loss of cell-surface receptor EphB2 is important for the growth, migration, and invasiveness of a colon cancer cell line |
| Q35645904 | Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis |
| Q59812843 | Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4 |
| Q45989150 | Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. |
| Q37633690 | Paradoxes of the EphB1 receptor in malignant brain tumors. |
| Q35928209 | Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma |
| Q64904071 | Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression. |
| Q54685952 | Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer. |
| Q38008491 | Regulation and misregulation of Eph/ephrin expression |
| Q45354950 | Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells |
| Q24338618 | SHARPIN is an endogenous inhibitor of β1-integrin activation |
| Q38006838 | The Eph/Ephrin family in cancer metastasis: communication at the service of invasion |
| Q36950556 | The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting |
| Q40252238 | The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway |
| Q34078717 | The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder |
| Q33301766 | The radiosensitizing effect of doranidazole on human colorectal cancer cells exposed to high doses of irradiation |
| Q27648574 | Three-dimensional Structure of the EphB2 Receptor in Complex with an Antagonistic Peptide Reveals a Novel Mode of Inhibition |
| Q45204638 | Transcriptional profiling identifies genes induced by hepatocyte-derived extracellular matrix in metastatic human colorectal cancer cell lines |
| Q37443849 | Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis. |
Search more.